Federal Register / Vol. 86, No. 173 / Friday, September 10, 2021 / Notices 50719 

MSC 7808, Bethesda, MD 20892, (240) 519– 

7808, kostrikr@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Intercellular 

Interactions Study Section 

Date: October 7, 2021. 

Time: 11:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Thomas Y. Cho, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–4179, thomas.cho@nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Cell 

Signaling and Molecular Endocrinology 

Study Section. 

Date: October 12–13, 2021. 

Time: 10:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Latha Malaiyandi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 812Q, 

Bethesda, MD 20892, (301) 435–1999, 

malaiyandilm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Innate 

Immunity and Inflammation. 

Date: October 13, 2021. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Liying Guo, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4198, 

MSC 7812, Bethesda, MD 20892, (301) 827– 

7728, lguo@mail.nih.gov. 

Name of Committee: Bioengineering 

Sciences & Technologies Integrated Review 

Group; Nanotechnology Study Section. 

Date: October 13–14, 2021. 

Time: 9:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joseph Thomas Peterson, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, (301) 408– 

9694, petersonjt@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Cancer Etiology Study Section. 

Date: October 13–14, 2021. 

Time: 10:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sarita Kandula Sastry, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20782, (301) 402–4788, sarita.sastry@nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Molecular and 

Integrative Signal Transduction Study 

Section. 

Date: October 13, 2021. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Zubaida Saifudeen, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20817, (301) 827–3029, zubaida.saifudeen@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Research to Improve Native American 

Health. 

Date: October 13, 2021. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sarah Vidal, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 710Q, 

Bethesda, MD 20892, (301) 402–6746, 

sarah.vidal@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 7, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19560 Filed 9–9–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group; Biobehavioral and Behavioral 

Sciences Study Section. 

Date: November 12, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Eunice 

Kennedy Shriver National Institute of Child 

Health and Human Development, 6710B 

Rockledge Drive, Room 2131A, Bethesda, MD 

20892 (Virtual Assisted Meeting). 

Contact Person: Clay Mash, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2131A, 

Bethesda, MD 20892, (301) 496–6866, 

mashc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: September 7, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–19558 Filed 9–9–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Stakeholder 

Measures and Advocate Forms at the 

National Cancer Institute (NCI) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 


jbell on DSKJLSW7X2PROD with NOTICES
50720 Federal Register / Vol. 86, No. 173 / Friday, September 10, 2021 / Notices 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Amy Williams, Director of the Office of 

Advocacy Relations (OAR), NCI, NIH, 

31 Center Drive, Bldg. 31, Room 10A28, 

MSC 2580, Bethesda, MD 20892, call 

non-toll-free number 240–781–3406, or 

email your request, including your 

address, to amy.williams@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on October 8, 2020, page 63565 

(Vol. 85 FR 63565) and allowed 60 days 

for public comment. No public 

comments were received. The National 

Cancer Institute (NCI), National 

Institutes of Health, may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Stakeholder 

Measures and Advocate Forms at the 

National Cancer Institute (NCI), OMB 

#0925–NEW: Expiration Date XX/XX/ 

XXXX, NEW, National Cancer Institute 

(NCI), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: The Office of Advocacy 

Relations (OAR) has collected data from 

different stakeholder constituencies: 

NIH and NCI staff, NCI-funded scientists 

and staff from universities and cancer 

centers, research advocates and their 

advocacy organizations, and members of 

scientific and professional societies and 

their organizations concerned about 

cancer. OAR uses the Profile 

Completion Questionnaire to capture 

applicant information such as basic 

contact information, age, gender, race 

and ethnicity, work focus, employment 

status, health experiences, and research 

advocacy experience. In addition, a 

post-activity survey is requested to 

ensure the advocates received property 

support by assessing satisfaction, 

expectations, involvement, barriers, and 

recruitment while working with the 

NCI. OAR continues to use the database 

system, which will allow this 

information to be collected 

electronically to match advocates easily 

and appropriately to NCI initiatives and 

activities as well as to assist NCI 

researchers in finding advocates to 

support their activities. In the previous 

three years, OAR has welcomed 49 

advocates into our network. Advocates 

have contributed to over 30 activities, 

ranging widely in scope and duration. 

Several examples include speaking 

engagements, Task Force appointments, 

Steering Committee appointments, 

webinars, Advisory Board 

appointments, etc. These forms were 

previously approved as, ‘‘Generic 

Submission for Formative Research, Pretesting, Stakeholder Measures and 

Advocate Forms at NCI’’ (OMB #: 0925– 

0641, Expiration Date: 1/31/2021). 

However, since OAR has not submitted 

Gen ICs for the past approvals this is 

being submitted as a new submission. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

16. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

time per 

response 

(in hours) 

Total annual 

burden hour 

Profile Completion ............................. Individuals ........................................ 30 1 30/60 15 

Survey ............................................... Individuals ........................................ 15 1 5/60 1 

Totals ......................................... ........................................................... ........................ 45 ........................ 16 

Dated: September 2, 2021. 

Diane Kreinbrink, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2021–19544 Filed 9–9–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, NIDA. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

NATIONAL INSTITUTE ON DRUG 

ABUSE, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, NIDA. 

Date: October 26, 2021. 

Time: 8:00 a.m. to 5:15 p.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institute on Drug Abuse, 

NIH, Biomedical Research Center, 251 

Bayview Boulevard, Baltimore, MD 21224 

(Virtual Meeting). 

Contact Person: Deon M. Harvey, Ph.D., 

Management Analyst, Office of the Scientific 

Director, National Institute on Drug Abuse, 

251 Bayview Boulevard, Room 04A314, 

Baltimore, MD 21224, (443) 740–2466, 

deon.harvey@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.277, Drug Abuse Scientist 

Development Award for Clinicians, Scientist 

Development Awards, and Research Scientist 

Awards; 93.278, Drug Abuse National 

Research Service Awards for Research 

Training; 93.279, Drug Abuse and Addiction 

Research Programs, National Institutes of 

Health, HHS) 


jbell on DSKJLSW7X2PROD with NOTICES